3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Central Nervous System Neoplasms
2
Thrombocytopenia
1
Testicular Neoplasms
1
Teratoma
1
Stomach Neoplasms
1
Sarcoma
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Ototoxicity
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Mouth Neoplasms
1
Mesothelioma, Malignant
1
Medulloblastoma
1
Lymphoma
1
Liver Neoplasms
1
Laryngeal Neoplasms
1
Intraocular Lymphoma
1
Hypopharyngeal Neoplasms
1
Hyperthermia
1
Hepatoblastoma
1
Gastrointestinal Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma
1
Brain Neoplasms
1
Adrenocortical Carcinoma
1
Adenocarcinoma
1
Interventions
Pemetrexed
12
Cisplatin
11
pembrolizumab
8
Carboplatin
6
Ipilimumab
5
Nivolumab
4
LMB-100
4
durvalumab
3
Gemcitabine
3
tremelimumab
2
tazemetostat
2
anetumab ravtansine
2
Vinorelbine
2
Plicamycin
2
Dexamethasone
2
Cyclophosphamide
2
Bevacizumab
2
vandetanib
1
tocilizumab
1
spartalizumab
1
ribociclib
1
rebastinib
1
pevonedistat
1
olaparib
1
niraparib
1
nintedanib
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
enzalutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma
×
sodium thiosulfate
×
Clear all
No trials found.